Search results
Results from the WOW.Com Content Network
On Wednesday, Johnson & Johnson (NYSE: JNJ) reported its second quarter results that reflected a strong momentum of its medtech and innovative medicine divisions. Although one-time charges ...
A jury ordered Johnson & Johnson to pay $260 million to an Oregon woman who said she developed ... its latest settlement proposal is to pay approximately $6.48 billion over 25 years to cover the ...
Over the past year, pharmaceutical and consumer staples giant Johnson & Johnson (NYSE:JNJ) has suffered from a split personality. On one hand, Johnson and Johnson offers multi-varied exposure to ...
The case centered on allegations that Johnson & Johnson’s talc-based products, including their iconic Baby Powder, contained asbestos, which ultimately led to Mr. Perry’s cancer. This lawsuit is part of a broader legal battle involving thousands of similar claims against Johnson & Johnson and other companies for their failure to ensure the ...
The U.S. was expected to authorize a third coronavirus vaccine, by Johnson & Johnson, as soon as Saturday. Latest COVID-19 updates. US administers about 2.4 million shots in a day, a new high ...
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.
Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready
Johnson & Johnson plans to split into two companies, separating its consumer health division that sells Band-Aids and Baby Powder from its pharmaceuticals and medical devices business in the ...